DFO, an iron chelator, exerts neuroprotective effects by reducing intracellular iron accumulation and suppressing the upregulation of ferritin heavy chain (FTH) and light chain (FTL), thereby alleviating local tissue deficits and cognitive impairments in rat models of TBI (225). The gene discussed is FTH1; the disease is Cognitive impairment.